Montevideo

Montevideo has solidified its reputation as a premier biotechnology hub in Latin America, offering a stable and collaborative environment for global life sciences investment.

The city is best known for its sophisticated pharmaceutical manufacturing infrastructure, housing over 50 state-of-the-art plants that serve as vital nodes in the global supply chain.

At the heart of its healthcare innovation is the Institut Pasteur de Montevideo, a world-class center driving breakthrough biomedical research and nurturing high-growth biotech startups.

The ecosystem excels in the development of oncolytic virus therapies, molecular diagnostics and skin microbiome innovations, often accelerated by specialized programs like Lab+.

Montevideo also functions as a strategic regional distribution center, leveraging tax-free zones to streamline medical device logistics and clinical supply chains.

Academic excellence is anchored by the University of the Republic, which fosters a deep pool of specialized talent in biochemistry and molecular biology.

Furthermore, the Pando Science and Technology Park bridges the gap between academic research and industrial application, fueling the growth of science-based ventures.

This convergence of public-private partnerships, robust intellectual property frameworks and clinical research capabilities makes Montevideo a destination of interest for multinational pharmaceutical companies.